LRRK2 and Parkinson disease: The most prevalent LRRK2 PD mutation, LRRK2 G2019S (Gilks et al, 2005), stimulates kinase activity (West et al, 2005) and disrupts the endolysosomal system in a variety of transgenic and cell models (Taylor and Alessi, 2020).